Trial record 1 of 1 for:
NCT05238493
A Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VEL-101
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05238493 |
|
Recruitment Status :
Completed
First Posted : February 14, 2022
Last Update Posted : December 21, 2023
|
Sponsor:
Veloxis Pharmaceuticals
Information provided by (Responsible Party):
Veloxis Pharmaceuticals
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | January 3, 2023 |
| Actual Study Completion Date : | January 3, 2023 |